HIV-1 envelope diversity and sensitivity to broadly neutralizing antibodies across stages of acute HIV-1 infection

Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc..

We studied the relationship between viral diversity and susceptibility to broadly neutralizing antibodies (bNAbs) in longitudinal plasma and peripheral blood mononuclear cells from 89 people with HIV who initiated antiretroviral therapy (ART) during acute and early HIV-1 infection (AEHI). HIV-1 diversity and predicted bNAb susceptibility were comparable across AEHI. Diversity evolution was not observed during ART, suggesting (pro)viruses at initiation or during treatment may identify individuals with susceptible virus for bNAb interventional trials.

Medienart:

E-Artikel

Erscheinungsjahr:

2024

Erschienen:

2024

Enthalten in:

Zur Gesamtaufnahme - volume:38

Enthalten in:

AIDS (London, England) - 38(2024), 4 vom: 15. März, Seite 607-610

Sprache:

Englisch

Beteiligte Personen:

VanderVeen, Laurie A [VerfasserIn]
Selzer, Lisa [VerfasserIn]
Moldt, Brian [VerfasserIn]
Parvangada, Aiyappa [VerfasserIn]
Li, Jiani [VerfasserIn]
Ananworanich, Jintanat [VerfasserIn]
Crowell, Trevor A [VerfasserIn]
Eron, Joseph J [VerfasserIn]
Daar, Eric S [VerfasserIn]
Haubrich, Richard [VerfasserIn]
Geleziunas, Romas [VerfasserIn]
Cyktor, Joshua [VerfasserIn]
Mellors, John W [VerfasserIn]
Callebaut, Christian [VerfasserIn]

Links:

Volltext

Themen:

Broadly Neutralizing Antibodies
Journal Article

Anmerkungen:

Date Completed 29.02.2024

Date Revised 03.03.2024

published: Print-Electronic

Citation Status MEDLINE

doi:

10.1097/QAD.0000000000003792

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM369064747